XML 49 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2012
Accounting Policies [Abstract]  
The assumptions used to value options granted
During years ended December 31, 2012, 2011 and 2010, the Company recorded income of $6,995,099, $556,662 and losses of $5,229,089, respectively, to adjust the value of the stock warrant liability to market.
 
 
2012
 
2011
 
2010
 
Stock Price
$0.64
 
$2.50
 
$2.27
 
Exercise Price
$1.52
 
$1.52
 
$1.52
 
Risk free interest rate
0.25
%
 
0.36
%
 
2.01
%
 
Expected term
2.25

 
3.25

 
4.25

 
Dividend yield

 

 

 
Expected volatility
103.1
%
 
83.24
%
 
95.89
%

The assumptions used to value options granted are as follows:
 
 
2012
 
2011
 
2010
 
Risk free interest rate
0.82
%
 
2.11
%
 
1.38
%
 
Expected term
4.75 years

 
4.75 years

 
4.75 years

 
Dividend yield

 

 

 
Expected volatility
93.57
%
 
92.72
%
 
92.45
%
Schedule of inventory
Inventories consist of the following:
 
 
December 31,
 
 
2012
 
2011
 
Raw materials
$
685,578

 
$
1,243,523

 
Work in process
1,308,399

 
825,466

 
Finished goods
632,629

 
1,566,741

 
Total
$
2,626,606

 
$
3,635,730

Schedule of useful lives or property and equipment
Depreciation is computed on the straight-line basis over the estimated useful lives of the respective assets, as follows:
 
Years
 
 
Software
3

Machinery and equipment
3.5-10

Furniture and fixtures
5

The calculation of basic and diluted income (loss) per common and common equivalent share
calculation of basic and diluted income (loss) per common and common equivalent share is as follows:
 
Years Ended December 31,
 
2012
 
2011
 
2010
INCOME (LOSS) PER SHARE -Basic
 
 
 
 
 
NET INCOME (LOSS)
$
9,917,273

 
$
20,527,192

 
$
(21,830,682
)
Less: Preferred stock dividends
(29,334
)
 
(30,000
)
 
(30,000
)
NET INCOME (LOSS) APPLICABLE TO
 
 
 
 
 
COMMON STOCK
$
9,887,939

 
$
20,497,192

 
$
(21,860,682
)
 
 
 
 
 
 
WEIGHTED AVERAGE NUMBER OF
 
 
 
 
 
COMMON SHARES OUTSTANDING: Basic:
87,315,808

 
86,325,350

 
73,462,937

 
 
 
 
 
 
NET INCOME (LOSS) PER COMMON SHARE: Basic
$
0.11

 
$
0.24

 
$
(0.30
)
 
 
 
 
 
 
INCOME (LOSS) PER SHARE -Diluted
 
 
 
 
 
NET INCOME (LOSS) APPLICABLE TO
 
 
 
 
 
COMMON STOCK
$
9,887,939

 
$
20,497,192

 
$
(21,860,682
)
Add: Preferred stock dividends
29,334

 
30,000

 

Less: Fair value of stock warrants for dilutive warrants
(6,995,099
)
 
(556,662
)
 

NET INCOME (LOSS) APPLICABLE TO
 
 
 
 
 
DILUTIVE COMMON STOCK
$
2,922,174

 
$
19,970,530

 
$
(21,860,682
)
 
 
 
 
 
 
WEIGHTED AVERAGE NUMBER OF
 
 
 
 
 
COMMON SHARES OUTSTANDING: Basic:
87,315,808

 
86,325,350

 
73,462,937

Effect of dilutive securities
 
 
 
 
 
Dilutive stock awards
48,866

 
1,357,712

 

Dilutive warrants

 
2,855,848

 

Dilutive preferred share conversions
1,139,600

 
2,010,243

 

 
1,188,466

 
6,223,803

 

WEIGHTED AVERAGE NUMBER OF
 
 
 
 
 
COMMON SHARES OUTSTANDING - Diluted:
88,504,274

 
92,549,153

 
73,462,937

 
 
 
 
 
 
NET INCOME (LOSS) PER COMMON SHARE: Diluted
$
0.03

 
$
0.22

 
$
(0.30
)
Schedule of accrued expenses
Accrued expenses consist of the following:
 
 
 
December 31,
 
 
 
 
2012
 
2011
 
 
Sales returns
 
$
483,865

 
$
1,429,597

 
 
Salaries
 
328,503

 
927,621

 
 
Severance costs
 
905,872

 

 
 
Professional fees
 
253,987

 
474,464

 
 
Royalties/Other
 
244,297

 
184,914

 
 
Total
 
$
2,216,524

 
$
3,016,596

 
The components of accumulated other comprehensive income
The components of accumulated other comprehensive income includes:
 
 
 
December 31,
 
 
 
2012
 
2011
 
Cumulative translation adjustment
 
$
186,001

 
$
182,883

 
Unrealized gain (loss) on short term investments
 
97,220

 
(77,981
)
 
Accumulated other comprehensive income (loss)
 
$
283,221

 
$
104,902



Reve
An analysis of the reserve for sales
An analysis of the reserve for sales returns follows:
 
 
2012
 
2011
 
2010
 
 
Balance at beginning of year
$
1,429,597

 
$
2,663,648

 
$
1,883,623

 
 
Provision:
 
 
 
 
 
 
 
Related to current period sales

 
52,487

 
934,190

 
 
Related to prior period sales
(625,452
)
 
305,800

 
847,427

 
 
 
(625,452
)
 
358,287

 
1,781,617

 
 
Returns:
 
 
 
 
 
 
 
Related to current period sales

 

 
(62,061
)
 
 
Related to 2006 Crinone® purchase

 

 

 
 
Related to prior period sales
(320,280
)
 
(1,592,338
)
 
(939,531
)
 
 
 
(320,280
)
 
(1,592,338
)
 
(1,001,592
)
 
 
Balance at end of period
$
483,865

 
$
1,429,597

 
$
2,663,648